Form 8-K - Current report:
SEC Accession No. 0000950170-23-021213
Filing Date
2023-05-11
Accepted
2023-05-11 16:06:11
Documents
13
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-20230511.htm   iXBRL 8-K 64809
2 EX-99.1 hrtx-ex99_1.htm EX-99.1 233975
  Complete submission text file 0000950170-23-021213.txt   437231

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrtx-20230511_pre.xml EX-101.PRE 11116
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrtx-20230511_lab.xml EX-101.LAB 17754
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrtx-20230511.xsd EX-101.SCH 2471
7 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20230511_htm.xml XML 4717
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 23910951
SIC: 2834 Pharmaceutical Preparations